A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/18 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01) C07K 16/22 (2006.01)
Patent
CA 2575901
The present invention relates generally to the field of cancer therapy and prophylaxis. More particularly, the present invention provides growth factor antagonists which inhibit the growth of cancers including tumors and pre- cancerous tissue. Even more particularly, the present invention is directed to antagonists of vascular endothelial growth factor-B and their use to inhibit the growth of cancer including tumor tissue and pre-cancerous tissue.
La présente invention concerne de façon générale le domaine de la thérapie et de la prophylaxie du cancer. Plus précisément, la présente invention concerne des antagonistes de facteur de croissance qui inhibent la croissance de cancers, notamment de tumeurs et de tissu précancéreux. Encore plus précisément, la présente invention concerne des antagonistes du facteur de croissance endothélial vasculaire B et leur utilisation pour inhiber la croissance du cancer, notamment de tissu tumoral et de tissu précancéreux.
Baca Manuel
Dunlop Felicity Meredith
Fabri Louis Jerry
Nash Andrew
Scotney Pierre David
Amrad Operations Pty. Ltd.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Zenyth Operations Pty Ltd
LandOfFree
A method of treating cancer comprising a vegf-b antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A method of treating cancer comprising a vegf-b antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A method of treating cancer comprising a vegf-b antagonist will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1456576